Facing The Upcoming Of Multidrug Resistant And Extensively Drug Resistant Bacteria Novel Antimicrobial Therapies Nats
Download Facing The Upcoming Of Multidrug Resistant And Extensively Drug Resistant Bacteria Novel Antimicrobial Therapies Nats full books in PDF, epub, and Kindle. Read online free Facing The Upcoming Of Multidrug Resistant And Extensively Drug Resistant Bacteria Novel Antimicrobial Therapies Nats ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
| Author | : Jun Lin |
| Publisher | : Frontiers Media SA |
| Total Pages | : 226 |
| Release | : 2015-06-01 |
| Genre | : Antibiotics |
| ISBN | : 2889195260 |
Antibiotics represent one of the most successful forms of therapy in medicine. But the efficiency of antibiotics is compromised by the growing number of antibiotic-resistant pathogens. Antibiotic resistance, which is implicated in elevated morbidity and mortality rates as well as in the increased treatment costs, is considered to be one of the major global public health threats (www.who.int/drugresistance/en/) and the magnitude of the problem recently prompted a number of international and national bodies to take actions to protect the public (http://ec.europa.eu/dgs/health_consumer/docs/road-map-amr_en.pdf: http://www.who.int/drugresistance/amr_global_action_plan/en/; http://www.whitehouse.gov/sites/default/files/docs/carb_national_strategy.pdf). Understanding the mechanisms by which bacteria successfully defend themselves against the antibiotic assault represent the main theme of this eBook published as a Research Topic in Frontiers in Microbiology, section of Antimicrobials, Resistance, and Chemotherapy. The articles in the eBook update the reader on various aspects and mechanisms of antibiotic resistance. A better understanding of these mechanisms should facilitate the development of means to potentiate the efficacy and increase the lifespan of antibiotics while minimizing the emergence of antibiotic resistance among pathogens.
| Author | : Angel León-Buitimea |
| Publisher | : Frontiers Media SA |
| Total Pages | : 136 |
| Release | : 2021-04-01 |
| Genre | : Science |
| ISBN | : 2889666530 |
| Author | : W. Scott Champney |
| Publisher | : Springer Science & Business Media |
| Total Pages | : 274 |
| Release | : 2008-01-15 |
| Genre | : Medical |
| ISBN | : 1588299155 |
This book examines specific techniques which can be used to explore new drug targets and the effectiveness of new antibiotics. By testing new antimicrobial agents and modified existing drugs, the most vulnerable cell processes, such as cell wall and membrane synthesis, DNA replication, RNA transcription and protein synthesis, can be better exploited. This in-depth volume, however, delves even deeper by identifying additional novel cellular targets for these new therapies. The book will provide laboratory investigators with the vital tools they need to test the antimicrobial potential of products and to curb the rise of so many infectious diseases.
| Author | : José-Luis Capelo-Martínez |
| Publisher | : John Wiley & Sons |
| Total Pages | : 730 |
| Release | : 2019-09-24 |
| Genre | : Medical |
| ISBN | : 1119282527 |
This book presents a thorough and authoritative overview of the multifaceted field of antibiotic science – offering guidance to translate research into tools for prevention, diagnosis, and treatment of infectious diseases. Provides readers with knowledge about the broad field of drug resistance Offers guidance to translate research into tools for prevention, diagnosis, and treatment of infectious diseases Links strategies to analyze microbes to the development of new drugs, socioeconomic impacts to therapeutic strategies, and public policies to antibiotic-resistance-prevention strategies
| Author | : Aníbal de J. Sosa |
| Publisher | : Springer Science & Business Media |
| Total Pages | : 553 |
| Release | : 2009-10-08 |
| Genre | : Science |
| ISBN | : 0387893709 |
Avoiding infection has always been expensive. Some human populations escaped tropical infections by migrating into cold climates but then had to procure fuel, warm clothing, durable housing, and crops from a short growing season. Waterborne infections were averted by owning your own well or supporting a community reservoir. Everyone got vaccines in rich countries, while people in others got them later if at all. Antimicrobial agents seemed at first to be an exception. They did not need to be delivered through a cold chain and to everyone, as vaccines did. They had to be given only to infected patients and often then as relatively cheap injectables or pills off a shelf for only a few days to get astonishing cures. Antimicrobials not only were better than most other innovations but also reached more of the world’s people sooner. The problem appeared later. After each new antimicrobial became widely used, genes expressing resistance to it began to emerge and spread through bacterial populations. Patients infected with bacteria expressing such resistance genes then failed treatment and remained infected or died. Growing resistance to antimicrobial agents began to take away more and more of the cures that the agents had brought.
| Author | : World Health Organization |
| Publisher | : |
| Total Pages | : 232 |
| Release | : 2014 |
| Genre | : Medical |
| ISBN | : 9789241564748 |
Summary report published as technical document with reference number: WHO/HSE/PED/AIP/2014.2.
| Author | : Thomas J. Dougherty |
| Publisher | : Springer Science & Business Media |
| Total Pages | : 1119 |
| Release | : 2011-12-18 |
| Genre | : Medical |
| ISBN | : 1461414008 |
This volume covers all aspects of the antibiotic discovery and development process through Phase II/III. The contributors, a group of highly experienced individuals in both academics and industry, include chapters on the need for new antibiotic compounds, strategies for screening for new antibiotics, sources of novel synthetic and natural antibiotics, discovery phases of lead development and optimization, and candidate compound nominations into development. Beyond discovery , the handbook will cover all of the studies to prepare for IND submission: Phase I (safety and dose ranging), progression to Phase II (efficacy), and Phase III (capturing desired initial indications). This book walks the reader through all aspects of the process, which has never been done before in a single reference. With the rise of antibiotic resistance and the increasing view that a crisis may be looming in infectious diseases, there are strong signs of renewed emphasis in antibiotic research. The purpose of the handbook is to offer a detailed overview of all aspects of the problem posed by antibiotic discovery and development.
| Author | : Institute of Medicine |
| Publisher | : National Academies Press |
| Total Pages | : 397 |
| Release | : 2003-08-25 |
| Genre | : Medical |
| ISBN | : 0309185548 |
Infectious diseases are a global hazard that puts every nation and every person at risk. The recent SARS outbreak is a prime example. Knowing neither geographic nor political borders, often arriving silently and lethally, microbial pathogens constitute a grave threat to the health of humans. Indeed, a majority of countries recently identified the spread of infectious disease as the greatest global problem they confront. Throughout history, humans have struggled to control both the causes and consequences of infectious diseases and we will continue to do so into the foreseeable future. Following up on a high-profile 1992 report from the Institute of Medicine, Microbial Threats to Health examines the current state of knowledge and policy pertaining to emerging and re-emerging infectious diseases from around the globe. It examines the spectrum of microbial threats, factors in disease emergence, and the ultimate capacity of the United States to meet the challenges posed by microbial threats to human health. From the impact of war or technology on disease emergence to the development of enhanced disease surveillance and vaccine strategies, Microbial Threats to Health contains valuable information for researchers, students, health care providers, policymakers, public health officials. and the interested public.
| Author | : Michael Robert Withington Brown |
| Publisher | : John Wiley & Sons |
| Total Pages | : 360 |
| Release | : 1975 |
| Genre | : Medical |
| ISBN | : |
| Author | : Donald L. Jungkind |
| Publisher | : Springer Science & Business Media |
| Total Pages | : 247 |
| Release | : 2013-06-29 |
| Genre | : Medical |
| ISBN | : 1475792034 |
Development and Implications of Antimicrobial Resistance One of the most ominous trends in the field of antimicrobial chemotherapy over the past decade has been the increasing pace of development of antimicrobial resistance among microbial pathogens. The hypothesis that man can discover a magic bullet to always cure a particular infection has proved false. Physicians are now seeing and treating patients for which there are few therapeutic alternatives, and in some cases, none at all. Until recently there was little concern that physicians might be losing the war in our ability to compete with the evolving resistance patterns of microbial pathogens. Now the general public is very aware of the threat to them if they become infected, thanks to cover story articles in major magazines such as Time, Newsweek, newspapers, and other news sources. Antimicrobial resistance is not a novel problem. Shortly after the widespread introduction of penicillin in the early 1940s, the first strains of penicillin-resistant staphylococci were described. Today it is an uncommon event for a clinical laboratory to isolate an S. aureus that is sensitive to penicillin. Other gram-positive strains of bacteria have become resistant, including the exquisitely sensitive Streptococcus pneumoniae. Sensitivity to vancomycin was once so uniform that it was used in routine clinical laboratories as a surrogate marker for whether an organism should be classified as a gram-positive. That criterion can no longer be relied upon because of emerging resistance among some species. Gram-negative bacteria, viruses, fungi, and parasites all have succeeded in developing resistance.
